Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor Antagonists

Mind the Gap: Model-Based Switching from Selatogrel to Maintenance Therapy with Oral P2Y12 Receptor Antagonists

<b>Background:</b> The P2Y<sub>12</sub> receptor antagonist selatogrel is being developed for subcutaneous self-administration with a ready-to-use autoinjector at the onset of acute myocardial infarction (AMI) symptoms. The unique pharmacological profile of selatogrel (fast,...

Full description

Bibliographic Details
Main Authors:	Chih-hsuan Hsin, Jasper Dingemanse, Andrea Henrich, Corine Bernaud, Martine Gehin, Andreas Krause
Format:	Article
Language:	English
Published:	MDPI AG 2023-09-01
Series:	Biomolecules
Subjects:	emergency treatment injections myocardial infarction P2Y<sub>12</sub> receptor antagonists platelet aggregation
Online Access:	https://www.mdpi.com/2218-273X/13/9/1365

Similar Items

The potency of selatogrel, a reversible antagonist of the P2Y12 receptor, is affected by calcium concentration
by: Martine Baumann, et al.
Published: (2022-01-01)

The P2Y12 Receptor Antagonist Selatogrel Dissolves Preformed Platelet Thrombi In Vivo
by: Lydie Crescence, et al.
Published: (2021-11-01)

Adenosine Receptor Agonists Increase the Inhibition of Platelet Function by P2Y<sub>12</sub> Antagonists in a cAMP- and Calcium-Dependent Manner
by: Nina Wolska, et al.
Published: (2020-07-01)

Unlocking the Conformational Changes of P2Y<sub>12</sub>: Exploring an Acridinone Compound’s Effect on Receptor Activity and Conformation
by: Belal O. Al-Najjar, et al.
Published: (2023-05-01)

Requiem for Rimonabant: Therapeutic Potential for Cannabinoid CB<sub>1</sub> Receptor Antagonists after the Fall
by: Taryn Bosquez-Berger, et al.
Published: (2023-08-01)

Design, Sustainable Synthesis and Biological Evaluation of a Novel Dual α2A/5-HT7 Receptor Antagonist with Antidepressant-Like Properties
by: Vittorio Canale, et al.
Published: (2021-06-01)

New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations
by: Giovanni Bolcato, et al.
Published: (2020-05-01)

Drug Repositioning of the α<sub>1</sub>-Adrenergic Receptor Antagonist Naftopidil: A Potential New Anti-Cancer Drug?
by: Romane Florent, et al.
Published: (2020-07-01)

Membrane Environment Modulates Ligand-Binding Propensity of P2Y12 Receptor
by: Fatemeh Haghighi, et al.
Published: (2021-04-01)

Platelet Reactivity and Outcomes after Off-Pump Coronary Surgery in Acute Coronary Syndrome Patients
by: Sarah Soh, et al.
Published: (2022-06-01)

Adenosine Receptors as Neuroinflammation Modulators: Role of A<sub>1</sub> Agonists and A<sub>2A</sub> Antagonists
by: Aleix Martí Navia, et al.
Published: (2020-07-01)

Pathophysiological Role and Medicinal Chemistry of A<sub>2A</sub> Adenosine Receptor Antagonists in Alzheimer’s Disease
by: Stefania Merighi, et al.
Published: (2022-04-01)

The Multi-Targeting Ligand ST-2223 with Histamine H<sub>3</sub> Receptor and Dopamine D<sub>2</sub>/D<sub>3</sub> Receptor Antagonist Properties Mitigates Autism-Like Repetitive Behaviors and Brain Oxidative Stress in Mice
by: Nermin Eissa, et al.
Published: (2021-02-01)

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022-01-01)

Combined Therapy of A<sub>1</sub>AR Agonists and A<sub>2A</sub>AR Antagonists in Neuroinflammation
by: Gabriella Marucci, et al.
Published: (2021-02-01)

P2Y<sub>12</sub> Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment
by: Fernanda Bueno Morrone, et al.
Published: (2021-10-01)

Antagonistic Skin Toxicity of Co-Exposure to Physical Sunscreen Ingredients Zinc Oxide and Titanium Dioxide Nanoparticles
by: Yan Liang, et al.
Published: (2022-08-01)

Design and Synthesis of 2,6-Disubstituted-4′-Selenoadenosine-5′-<em>N</em>,<em>N</em>-Dimethyluronamide Derivatives as Human A<sub>3</sub> Adenosine Receptor Antagonists
by: Hongseok Choi, et al.
Published: (2021-04-01)

Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus
by: Dawid Polak, et al.
Published: (2021-03-01)

The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y<sub>12</sub> Pathway in Multiple Sclerosis
by: Angela Dziedzic, et al.
Published: (2021-06-01)

P2Y<sub>12</sub> Inhibition in Murine Myocarditis Results in Reduced Platelet Infiltration and Preserved Ejection Fraction
by: Sarah Nasreen Schmidt, et al.
Published: (2021-12-01)

Antiplatelet Effects of Selected Xanthine-Based Adenosine A<sub>2A</sub> and A<sub>2B</sub> Receptor Antagonists Determined in Rat Blood
by: Monika Kubacka, et al.
Published: (2023-08-01)

Guanidines: Synthesis of Novel Histamine H<sub>3</sub>R Antagonists with Additional Breast Anticancer Activity and Cholinesterases Inhibitory Effect
by: Marek Staszewski, et al.
Published: (2023-04-01)

Modeling time‐delayed concentration‐QT effects with ACT‐1014‐6470, a novel oral complement factor 5a receptor 1 (C5a1 receptor) antagonist
by: Marion Anliker‐Ort, et al.
Published: (2023-08-01)

Design and Synthesis of Conformationally Flexible Scaffold as Bitopic Ligands for Potent D<sub>3</sub>-Selective Antagonists
by: Ho Young Kim, et al.
Published: (2022-12-01)

Effect of MPV and β<sub>2</sub>-microglobulin on cardiac valve calcification in patients on maintenance hemodialysis
by: Yao Zhuan’ e, Wang Pengbo, Fu Qinjuan, Wang Wei, Song Qiong, Li Huan, Liu Ai, Zhang Peng
Published: (2023-09-01)

Vitamin B<sub>12</sub> Status and Optimal Range for Hemoglobin Formation in Elite Athletes
by: Jarosław Krzywański, et al.
Published: (2020-04-01)

Histamine H<sub>2</sub>-Receptor Antagonists Improve Non-Steroidal Anti-Inflammatory Drug-Induced Intestinal Dysbiosis
by: Rei Kawashima, et al.
Published: (2020-10-01)

Preclinical studies of RUC-4, a novel platelet αIIbβ3 antagonist, in non-human primates and with human platelets
by: Spandana Vootukuri, et al.
Published: (2019-06-01)

Response of Human Glioblastoma Cells to Vitamin B12 Deficiency: A Study Using the Non-Toxic Cobalamin Antagonist
by: Zuzanna Rzepka, et al.
Published: (2021-01-01)

Preparation and Photocatalytic Performance for Degradation of Rhodamine B of AgPt/Bi<sub>4</sub>Ti<sub>3</sub>O<sub>12</sub> Composites
by: Gaoqian Yuan, et al.
Published: (2020-11-01)

Use of glycoprotein IIb/IIIa antagonists to prevent stent thrombosis in morphine-treated patients with ST-elevation myocardial infarction
by: Bastiaan Zwart, et al.
Published: (2020-02-01)

Rational Design, Stabilities and Nonlinear Optical Properties of Non-Conventional Transition Metalides; New Entry into Nonlinear Optical Materials
by: Mohammed A. Alkhalifah, et al.
Published: (2023-04-01)

Prevalence and Risk Factors of Vitamin B<sub>12</sub> Deficiency among Pregnant Women in Rural Bangladesh
by: Odunayo Ifeoluwa Sobowale, et al.
Published: (2022-05-01)

De-Escalation of Antiplatelet Treatment in Patients with Myocardial Infarction Who Underwent Percutaneous Coronary Intervention: A Review of the Current Literature
by: Daniel MF Claassens, et al.
Published: (2020-09-01)

Molecular screening for potential selective antagonists of TRPA<sub>1</sub> ion channel
by: E. A. Beskhmelnitsyna, et al.
Published: (2018-02-01)

A Comparative Study of Eu<sup>3+</sup>-Doped Sillenites: Bi<sub>12</sub>SiO<sub>20</sub> (BSO) and Bi<sub>12</sub>GeO<sub>20</sub> (BGO)
by: Marcin Kowalczyk, et al.
Published: (2023-02-01)

Randomized controlled trial protocol to investigate the antiplatelet therapy effect on extracellular vesicles (AFFECT EV) in acute myocardial infarction
by: Aleksandra Gasecka, et al.
Published: (2020-01-01)

Preliminary Evidence of the Potent and Selective Adenosine A2B Receptor Antagonist PSB-603 in Reducing Obesity and Some of Its Associated Metabolic Disorders in Mice
by: Magdalena Kotańska, et al.
Published: (2022-11-01)

(α1, 2, β1, 2)-complex intuitionistic fuzzy subgroups and its algebraic structure
by: Doaa Al-Sharoa
Published: (2023-01-01)